The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona

被引:14
|
作者
Herrera, Sabina [1 ]
Guelar, Ana [1 ]
Sorli, Luisa [1 ]
Vila, Joan [2 ]
Molas, Ema [1 ]
Grau, Maria [2 ]
Marrugat, Jaume [2 ]
Esteve, Erika [1 ]
Gueerri-Fernandez, Roberto [1 ]
Montero, Milagro [1 ]
Knobel, Hernando [1 ]
机构
[1] Hosp Mar, Dept Infect Dis, Barcelona 08003, Spain
[2] IMIM Hosp Mar Med Res Inst, Cardiovasc Epidemiol & Genet, Barcelona, Spain
来源
HIV CLINICAL TRIALS | 2016年 / 17卷 / 04期
关键词
Cardiovascular risk; Framingham; HIV; REGICOR; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; ANTIRETROVIRAL THERAPY; EUROPEAN POPULATIONS; CORONARY-DISEASE; MORTALITY-RATES; DATA-COLLECTION; TASK-FORCE; SPAIN; TRENDS;
D O I
10.1080/15284336.2016.1177266
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Cardiovascular risk (CVR) assessment helps to identify patients at high CVR. The Framingham CVR score (FRS) is the most widely used methods but may overestimate risk in regions with low incidence of cardiovascular disease. The objective was to compare the 10-year performance of the original and the adapted REGICOR - Framingham CVR functions in HIV-infected individuals. Methods: We carried out a longitudinal study of HIV-infected patients with CVR evaluation in a hospital in Barcelona between 2003 and 2013. Statistics: Risk probability was calculated using the FRAMINGHAM function and REGICOR adaptation to the Spanish population, and individuals were categorized in three groups (low, 0 < 5%; moderate, 5-10%; and high, > 10%). For each risk group, the number of events over 10 years was calculated using the Kaplan-Meier method, and the expected number of events was calculated by multiplying the frequency of participants in the group by the mean of the probabilities from the risk function. We used the X-2 goodness-of-fit test to assess agreement between observed and expected. Results: Six hundred and forty-one patients were followed up for a median of 10.2 years, and 20 ischemic heart events (IHE) were observed. The mean (95% CI) number of IHEs per 1000 person-years was 3.7 (2.06-5.27). The estimates from the Framingham and REGICOR functions were 40 and 14 IHEs, respectively. The estimate from the original Framingham function differed significantly from the observed incidence (p < 0.001), whereas that from the REGICOR-adapted function did not (p = 0.15). In terms of the number of cardiovascular events (38 events observed), the REGICOR function significantly underestimated risk (p = 0.01), whereas the estimate from the Framingham function was similar to observed (p: 0.93). Conclusions: The FRS significantly overestimates risk of IHE events in our HIV-infected patients, while the REGICOR function is a better predictor of these events. In terms of cardiovascular events, the REGICOR function significantly underestimates risk, whereas the FRS is a better estimator. We recommend using CVR scales and adjusting them to the origin of the population being studied.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [21] Coronary heart disease in HIV-infected individuals
    Vittecoq, D
    Escaut, L
    Merad, M
    Teicher, E
    Monsuez, JJ
    Chironi, G
    [J]. HIV INFECTION AND THE CARDIOVASCULAR SYSTEM, 2003, 40 : 151 - 162
  • [22] Cardiovascular risk in HIV-infected patients
    Reis, Roberto Palma
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2019, 38 (07) : 471 - 472
  • [23] Cardiovascular risk assessment in HIV-infected male patients: a comparison of Framingham, SCORE, PROCAM and DAD risk equations
    Pirs, Mateja
    Jug, Borut
    Erzen, Barbara
    Sabovic, Miso
    Karner, Primoz
    Poljak, Mario
    Tomazic, Janez
    [J]. ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2014, 23 (03): : 43 - 47
  • [24] Kidney disease in HIV-infected patients
    Scarpino, M.
    Pinzone, M. R.
    Di Rosa, M.
    Madeddu, G.
    Foca, E.
    Martellotta, F.
    Schioppa, O.
    Ceccarelli, G.
    Celesia, B. M.
    d'Ettorre, G.
    Vullo, V.
    Berretta, S.
    Cacopardo, B.
    Nunnari, G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (19) : 2660 - 2667
  • [25] Pneumococcal disease in HIV-infected patients
    Lesprit, P
    Decazes, JM
    [J]. PRESSE MEDICALE, 1997, 26 (05): : 243 - 247
  • [26] Endothelial function in HIV-infected patients with low or mild cardiovascular risk
    Rios Blanco, Juan Jose
    Suarez Garcia, Ines
    Gomez Cerezo, Jorge
    Jose Maria Pena Sanchez de Rivera
    Moreno Anaya, Pilar
    Garcia Raya, Pilar
    Gonzalez Garcia, Juan
    Arribas Lopez, Jose Ramon
    Barbado Hernandez, Francisco Javier
    Vasquez Rodriguez, Juan Jose
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (01) : 133 - 139
  • [27] GRAVES DISEASE IN HIV-INFECTED PATIENTS
    Modarressi, Taher
    [J]. ENDOCRINE PRACTICE, 2020, 26 (10) : 1227 - 1227
  • [28] Anorectal disease in HIV-infected patients
    Yuhan, R
    Orsay, C
    DelPino, A
    Pearl, R
    Pulvirenti, J
    Kay, S
    Abcarian, H
    [J]. DISEASES OF THE COLON & RECTUM, 1998, 41 (11) : 1367 - 1370
  • [29] HEART FAILURE ADMISSION IN HIV-INFECTED PATIENTS
    Bahrami, Hossein
    Fonarow, Gregg
    Heidenreich, Paul
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1351 - A1351
  • [30] HEART TRANSPLANTATION IN TWO HIV-INFECTED PATIENTS
    Mina, Chiara
    Clemenza, Francesco
    Balsamo, Maria Luisa
    Di Gesaro, Gabriele
    Falletta, Calogero
    Mularoni, Alessandra
    Scardulla, Cesare
    Grossi, Paolo Antonio
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 107 - 107